This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shearer, B. G. Articles by Billin, A. N. Search for Related Content PubMed PubMed Citation Articles by Shearer, B. G. Articles by Billin, A. N.

Identification and Characterization of a Selective Peroxisome Proliferator-Activated Receptor β/ (NR1C2) Antagonist

GlaxoSmithKline (B.G.S., J.M.W., T.B.S., D.C.L., M.A.I., T.M.W., A.N.B.), Research and Development, Research Triangle Park, North Carolina 27709; GlaxoSmithKline (D.A.G.), Research and Development, 91951 Les Ulis, France; and Division of Endocrinology, Diabetes, and Metabolism (D.J.S., M.A.L.), Department of Medicine, The Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

Address all correspondence and requests for reprints to: Andrew N. Billin, GlaxoSmithKline, Research and Development, Research Triangle Park, North Carolina 27709. E-mail: andrew.n.billin{at}GSK.com.

ABSTRACT

The identification of small molecule ligands for the peroxisome proliferator-activated receptors (PPARs) has been instrumental in elucidating their biological roles. In particular, agonists have been the focus of much of the research in the field with relatively few antagonists being described and all of those being selective for PPAR or PPAR. The comparison of these agonist and antagonist ligands in cellular and animal systems has often led to surprising results and new insights into the biology of the PPARs. The PPARβ/ receptor is emerging as an important regulator of energy metabolism, inflammation, and cell growth and differentiation; however, only agonist ligands have been described for this receptor thus far. Here we describe the first report of a PPARβ/ small molecule antagonist ligand. This antagonist ligand will be a useful tool for elucidating the biological roles of PPARβ/.

NURSA Molecule Pages Link:

Nuclear Receptors:   PPARδ

Ligands:   GW0742X

This article has been cited by other articles:

				Y.-M. Sue, C.-P. Chung, H. Lin, Y. Chou, C.-Y. Jen, H.-F. Li, C.-C. Chang, and S.-H. Juan PPAR{delta}-mediated p21/p27 induction via increased CREB-binding protein nuclear translocation in beraprost-induced antiproliferation of murine aortic smooth muscle cells Am J Physiol Cell Physiol, August 1, 2009; 297(2): C321 - C329. [Abstract] [Full Text] [PDF]

				X. Zuo, Z. Peng, M. J. Moussalli, J. S. Morris, R. R. Broaddus, S. M. Fischer, and I. Shureiqi Targeted Genetic Disruption of Peroxisome Proliferator-Activated Receptor-{delta} and Colonic Tumorigenesis J Natl Cancer Inst, May 20, 2009; 101(10): 762 - 767. [Abstract] [Full Text] [PDF]

				L. Zeng, Y. Geng, M. Tretiakova, X. Yu, P. Sicinski, and T. G. Kroll Peroxisome Proliferator-Activated Receptor-{delta} Induces Cell Proliferation by a Cyclin E1-Dependent Mechanism and Is Up-regulated in Thyroid Tumors Cancer Res., August 15, 2008; 68(16): 6578 - 6586. [Abstract] [Full Text] [PDF]